Shah Capital has urged Novavax's board to pursue a sale of the biotech, citing a third consecutive year of poor rollout of ...

Activist investor Shah Capital has called on the board of directors at Novavax to put the company up for sale, citing a ...

Shah Capital renews pressure on Novavax board, saying the biotech’s underperformance calls for a strategic sale to unlock ...

Himanshu Shah, managing partner and chief investment officer at Shah Capital, slammed management, and said the company should ...

In August, the U.S. Food and Drug Administration approved the new COVID-19 booster shots, but with certain restrictions.

AstraZeneca followed the blueprint of a deal Pfizer recently cut with the White House. Elsewhere, Novo is shuttering its cell ...

Winter edges in and, like clockwork, Covid-19, influenza and respiratory syncytial virus step back into the ...

Alongside the new COVID-19 vaccination guidelines, the CDC has made adjustments to its recommendations for toddler ...

Novavax Inc on Friday outlined specific diversity targets for its large-scale COVID-19 vaccine study expected to begin in the United States and Mexico next month.

It’s that time of year when the leaves are turning golden, there’s a chill in the air and the threat of respiratory viruses ...

Amid confusion over this year's updated COVID-19 vaccines, we explain what's different this year and who experts say should ...

Trump's physician, Sean Barbabella, shared news of the president's COVID vaccination in a letter to White House press ...